ArticlePediatric quality & safety

Quality Improvement Methodology Optimizes Infliximab Levels in Pediatric Patients with Inflammatory Bowel Disease.

Jennifer Hellmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.